Skip to main content
Figure 4 | Journal of Translational Medicine

Figure 4

From: Renal cell neoplasias: reversion-inducing cysteine-rich protein with Kazal motifs discriminates tumor subtypes, while extracellular matrix metalloproteinase inducer indicates prognosis

Figure 4

EMMPRIN is a prognostic marker in renal cell carcinoma. Kaplan-Meier analyses show RECK-positive (0) and RECK-negative (1–3) staining intensities (A) or low EMMPRIN (0/1) and high EMMPRIN (2/3) staining intensities (B) connected with overall survival of the patients after nephrectomy. Oncocytomas were excluded. Curves of all 387 cases (386 for EMMPRIN) are shown at the left, curves of the selected 181 pN0/M0 cases only (180 for EMMPRIN) are depicted at the right. High EMMPRIN expression was significantly associated with a decrease in overall survival, even in pN0/M0 cases only, while RECK did not discriminate subgroups. Censored cases are marked (+).

Back to article page